Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cell Medx Corp (CMXC)

Cell Medx Corp (CMXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2000 +50.00%
on 01/29/20
0.3300 -9.09%
on 02/12/20
+0.0700 (+30.43%)
since 01/24/20
3-Month
0.1645 +82.37%
on 12/11/19
0.4200 -28.57%
on 11/26/19
-0.1199 (-28.55%)
since 11/25/19
52-Week
0.1020 +194.12%
on 08/07/19
1.6900 -82.25%
on 09/18/19
+0.1000 (+50.00%)
since 02/21/19

Most Recent Stories

More News
Cell MedX Corp. Reacquires World Wide Exclusivity Rights for the eBalance(R) Device

Carson City, Nevada--(Newsfile Corp. - January 30, 2020) -  ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic...

LIVC : 0.0753 (-5.87%)
CMXC : 0.3000 (unch)
Live Current Sells eBalance Distribution Rights to Focus Exclusively on eSports and Gaming

VANCOUVER, BC / ACCESSWIRE / January 29, 2020 / Live Current Media, Inc. ("Live Current" or the "Company") (OTCQB:LIVC) announces that it has entered into an agreement to sell the exclusive distribution...

CMXC : 0.3000 (unch)
LIVC : 0.0753 (-5.87%)
Cell MedX Corp. Engages Dr. Peter Eppinga as Lead Investigator in the eBalance(R) R&D Experience Study

Carson City, Nevada--(Newsfile Corp. - December 12, 2019) - ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic...

CMXC : 0.3000 (unch)
Cell MedX Corp. Receives eBalance Trademark

Carson City, Nevada--(Newsfile Corp. - October 17, 2019) - ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic...

CMXC : 0.3000 (unch)
Cell MedX Corp. Provides Corporate Update

Carson City, Nevada--(Newsfile Corp. - September 12, 2019) - ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic...

CMXC : 0.3000 (unch)
Cell MedX Corp. Issues Clarifying Release Regarding the Bull Report Article

Carson City, Nevada--(Newsfile Corp. - September 10, 2019) - ("Cell MedX" or the "Company"), a biotech company focused on the discovery, development and commercialization of therapeutic and nontherapeutic...

CMXC : 0.3000 (unch)
CellMedX Corp. Receives Approval to Commence Family Practice (BC) Observational Study

Carson City, Nevada--(Newsfile Corp. - August 19, 2019) - ), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general...

CMXC : 0.3000 (unch)
Cell MedX Corp. (CMXC) Closes the First Tranche of its Non-Brokered Private Placement Financing

Carson City, Nevada--(Newsfile Corp. - June 28, 2019) - ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic...

CMXC : 0.3000 (unch)
Cell MedX Corp. Engages Think Ink Marketing

Carson City, Nevada--(Newsfile Corp. - June 21, 2019) - Cell MedX Corp. ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and...

CMXC : 0.3000 (unch)
Cell MedX Signs Definitive Worldwide Distribution Rights Agreement with Live Current Media, Inc.

Carson City, Nevada--(Newsfile Corp. - March 27, 2019) - Cell MedX Corp. ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and...

CMXC : 0.3000 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade CMXC with:

Key Turning Points

2nd Resistance Point 0.3267
1st Resistance Point 0.3133
Last Price 0.3000
1st Support Level 0.2833
2nd Support Level 0.2667

See More

52-Week High 1.6900
Fibonacci 61.8% 1.0834
Fibonacci 50% 0.8960
Fibonacci 38.2% 0.7086
Last Price 0.3000
52-Week Low 0.1020

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar